Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-03-07

Clinical Trial Update: How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia [NA]

View source ↗

Summary

The clinical trial evaluating a driving-related virtual reality tool to improve quality of life and social autonomy in schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Driving Virtual Reality Tool

Snippet

Sponsor: Hôpital le Vinatier | Conditions: Schizophrenia | NA | Status: WITHDRAWN